-
公开(公告)号:US20240228086A1
公开(公告)日:2024-07-11
申请号:US18615822
申请日:2024-03-25
发明人: Syou OUMI , Shiyouji SHIBATA , Toshiaki UETA
摘要: A drug supply apparatus of the present disclosure includes a drug supply unit configured to supply a drug to a drug delivery position; a downstream conveying unit configured to convey a strip-shaped first drug packaging paper, folded in half in advance along its longitudinal direction and configured to receive a drug at the drug delivery position; and an upstream conveying unit configured to convey a strip-shaped second drug packaging paper, folded in half in advance along its longitudinal direction. In the apparatus, the upstream conveying unit conveys the second drug packaging paper toward the first drug packaging paper in such a way that the downstream end part of the second drug packaging paper holds in its inside the upstream end part of the first drug packaging paper, and the ridge line of the second drug packaging paper overlaps the ridge line of the first drug packaging paper.
-
公开(公告)号:US11975274B2
公开(公告)日:2024-05-07
申请号:US17945125
申请日:2022-09-15
申请人: Velico Medical, Inc.
发明人: Qiyong Peter Liu , Herman E. Snyder , Kyle D. Erickson , Evan P. Ordway , William J. Merritt , Richard Meehan , Robert R. Andrews , Clair Strohl , Jihae Sohn , Mark A. Popovsky , Lisa A. Buckley
摘要: The present invention relates to a spray dried plasma composition having one or more of the following characteristics: when reconstituted, largely amorphous and has no cholesterol crystals; when reconstituted, the number of large particulates is reduced; has low residual moisture; reconstitutes rapidly in under four minutes; highly stable when stored under refrigeration, at room temperature or at elevated temperatures and allows for storage for longer periods of time; when reconstituted, exhibits recovery of the most fragile of proteins, including von Willebrand's factor; when reconstituted with Sterile Water for Injection (SWFI), reconstituted plasma is at a pH that is near normal plasma pH, and does so without treatment or storage in CO2 or other pH adjustment; and when reconstituted, has reduced complement activation (C5A, C3A).
-
公开(公告)号:US20240100312A1
公开(公告)日:2024-03-28
申请号:US18531447
申请日:2023-12-06
发明人: William Brian Austin , Edward J. McPherson , Andrew J. Wassef , Scott P. Noel , Stephen T. Miller
CPC分类号: A61M37/0069 , A61J3/00
摘要: Devices and methods for mixing and preparing therapeutic pellets are described. In one aspect, the present disclosure may include a medical device for mixing and preparing pharmaceuticals. The medical device may include a body sized and shaped to be supported by a human hand. The body may be elastically flexible between a relaxed shape and a flexed shape. In the relaxed shape, the body may form a basin and may be shaped and sized to receive a vessel for mixing or forming the therapeutic pellets. In the flexed shape, the bowl may be configured for controlled pouring of the therapeutic pellets.
-
公开(公告)号:US20240091666A1
公开(公告)日:2024-03-21
申请号:US18097958
申请日:2023-01-17
申请人: Velico Medical, Inc.
发明人: Richard Meehan , Robert R. Andrews , Herman E. Snyder , William J. Merritt , Evan P. Ordway , Clair Strohl , Qiyong Peter Liu , Jihae Sohn
摘要: The present invention relates to a spray dried plasma composition having one or more of the following characteristics: when reconstituted, largely amorphous and has no cholesterol crystals; when reconstituted, the number of large particulates is reduced; has low residual moisture; reconstitutes rapidly in under four minutes; highly stable when stored under refrigeration, at room temperature or at elevated temperatures and allows for storage for longer periods of time; when reconstituted, exhibits recovery of the most fragile of proteins, including von Willebrand's factor; when reconstituted with Sterile Water for Injection (SWFI), reconstituted plasma is at a pH that is near normal plasma pH, and does so without treatment or storage in CO2 or other pH adjustment; and when reconstituted, has reduced complement activation (C5A, C3A).
-
公开(公告)号:US11930810B2
公开(公告)日:2024-03-19
申请号:US16332709
申请日:2017-09-12
申请人: 77 KC CO., LTD.
发明人: Hirohide Komatsu , Tsutomu Sawa
IPC分类号: A01N1/02 , A61B17/43 , A61B17/435 , A61D19/02 , A61J3/00 , C12M1/24 , G06K19/077
CPC分类号: A01N1/0268 , A01N1/02 , A61B17/43 , A61B17/435 , A61D19/02 , A61D19/024 , A61J3/00 , C12M1/24 , G06K19/077 , G06K19/07758
摘要: Provided is a cryopreservation container that prevents confusion of specimens to be used for treatment and that is suitable for individual management of fertilized eggs and the like to be cryopreserved. IC tags are attached to a cryopreservation tank 61, a canister 51, a cane 41, and cryopreservation containers such as an ovum storage container 1 and sperm storage containers 71, 81. The cryopreservation containers may also have individual identification codes attached hereto. An ovum storage container 11 is configured by fitting an IC tag 12 from the rear end of a rod-like part 2 of a conventional ovum storage container 1. In addition, the IC tag 12 is formed by providing an inlet 15 inside a thin-walled pipe 14 made of a synthetic resin. The inlet 15 may be fixed at both ends by means of fixing members 18, 18 composed of a nonconductive material, or may be integrally molded with a nonconductive synthetic resin material 20.
-
公开(公告)号:US11648556B2
公开(公告)日:2023-05-16
申请号:US17061247
申请日:2020-10-01
发明人: Pieter R. Cullis , Igor V. Jigaltsev , Robert James Taylor , Timothy Leaver , Andre Wild , Nathan Maurice Belliveau
IPC分类号: A61F13/00 , B01L3/00 , A61K9/107 , A61K9/127 , B01F23/41 , B01F25/431 , B01F25/433 , B01F33/30 , A61K9/14 , A61K31/704 , A61K47/44 , A61K49/00 , A61J3/00
CPC分类号: B01L3/50273 , A61J3/00 , A61K9/1075 , A61K9/127 , A61K9/1271 , A61K9/1277 , A61K9/14 , A61K31/704 , A61K47/44 , A61K49/0002 , B01F23/41 , B01F25/431 , B01F25/4331 , B01F33/30 , B01L3/502715 , B01F25/431971 , B01L2200/0605 , B01L2200/0647 , B01L2300/06 , B01L2300/0848 , B01L2300/0867 , B01L2300/18 , Y10T428/2982
摘要: Limit size lipid nanoparticles, methods for using the lipid nanoparticles, and methods and systems for making limit size lipid nanoparticles.
-
公开(公告)号:US20180369071A1
公开(公告)日:2018-12-27
申请号:US15779837
申请日:2016-11-28
发明人: Naoki KOIKE , Takanori YOROZU , Shoichiro OKADA , Kenich TAKADA
IPC分类号: A61J7/00
CPC分类号: A61J7/0076 , A61J3/00 , A61J2200/72 , A61J2205/30 , G07F11/54 , G07F17/0092
摘要: A medicine cassette 100 includes a side-wall constituent body 110, a first rotating body 120, a second rotating body 130 and a medicine discharging part 144c. The medicine cassette 100 can scrape up medicines prepared in a medicine containing part 182 along with a rotation of the first rotating body 120 to transfer and place the medicines onto the second rotating body 130 and transfer the medicines toward a downstream side of a rotational direction of the second rotating body 130 to discharge the medicines from the medicine discharging part 144c. An expanding portion 110a expanding toward an outer side of a radial direction of the second rotating body 130 is provided in the side-wall constituent body 110 on a lower side of the second rotating body 130.
-
8.
公开(公告)号:US20180318731A1
公开(公告)日:2018-11-08
申请号:US15969936
申请日:2018-05-03
发明人: Jürgen SEBASTIAN
CPC分类号: B01D25/32 , A61J3/00 , A61M1/3496 , A61M2202/0415 , B01D25/12 , B01D25/164 , B01D25/215 , B01D25/285 , B01D41/04 , B01D2201/342 , B01D2201/345
摘要: A plate for a filter press, a filter press, the use of such a filter press as well as a method of cleaning and sterilization of such a filter press. The plate for a filter press has a base body, consisting of a first material with a hardness H1 and having an outer circumferential surface, and a frame arranged on the outer circumferential surface, consisting of a second material with a hardness H2, where H2
-
公开(公告)号:US20180227359A1
公开(公告)日:2018-08-09
申请号:US15941455
申请日:2018-03-30
申请人: William Reber, LLC
发明人: William L. Reber
IPC分类号: H04L29/08 , B33Y50/02 , G06Q30/04 , B29C64/386
CPC分类号: H04L67/10 , A61J3/00 , B29C64/386 , B33Y50/02 , G05B15/02 , G05B19/18 , G05B19/4099 , G05B2219/49023 , G06F1/3203 , G06F9/5094 , G06Q20/22 , G06Q30/04 , H04L67/12 , H04L67/18 , H04L67/32 , H04W4/80 , Y02D10/159 , Y02D10/22
摘要: A cloud computing system includes a network interface for interfacing with a wide area network. At least one wireless transceiver engages in bidirectional communication with a plurality of vehicle cloud processing devices within a corresponding plurality of vehicles in at least one vehicle aggregation location. A network control device receives requests for at least one cloud computing service via the wide area network and facilitates the at least one cloud computing service via the bidirectional communication with the plurality of vehicle cloud processing devices.
-
公开(公告)号:US20180174292A1
公开(公告)日:2018-06-21
申请号:US15896242
申请日:2018-02-14
申请人: FUJIFILM Corporation
发明人: Tetsuya TAKAMORI
CPC分类号: G06T7/0004 , A61J3/00 , G06K9/2063 , G06K9/34 , G06K9/344 , G06K9/4604 , G06K2009/2045 , G06K2209/01 , G16H20/10 , G16H20/13 , G16H30/40
摘要: A drug inspection device includes an image acquisition unit that acquires a plurality of captured images obtained by imaging a bundle of drug sheets bundled in a state where at least some thereof overlap each other, the image acquisition unit acquiring the captured images including at least some of respective drug sheets with respect to all the drug sheets; a drug classification specifying unit that specifies a drug classification from the captured images; an outer edge information extraction unit that extracts information of an outer edge of each of the drug sheets from the captured images; a number-of-sheets counting unit that counts the number of drug sheets based on the information; an outermost layer sheet specifying unit that specifies an outermost layer sheet present on an outermost surface portion of the bundle; and a first drug counting unit that counts the number of drugs in the outermost layer sheet.
-
-
-
-
-
-
-
-
-